In a typical US deal, a management company backed by a private equity fund buys the non-clinical side of the practice. You get cash at closing and equity in the larger company, sign a multi-year employment agreement and a non-compete, and keep clinical decisions.1 The upside is money now and a possible second payout when the fund sells. The cost is lower pay, less control over the business, and a new owner that plans to sell within a few years.
How a private equity deal is built
Many US states don't let a lay company practice medicine or employ physicians to do it, so private equity buyers split the practice in two. The physicians keep (or a physician owns) the professional entity that holds the licenses and provides care. A management services organization (MSO), owned by the fund, buys everything else: equipment, staff, leases, systems and the right to run the business side under a long-term management agreement. MSOs and the corporate practice of medicine explains the legal reasoning.
For you, the deal usually comes in three parts: a sale of the non-clinical assets, an employment agreement, and equity in the buyer that you "roll over" from your sale proceeds.1
The first practice a fund buys in a specialty and region is the platform. Practices bought afterwards are add-ons. Platforms are bigger and get higher multiples. Add-ons are priced lower and fold into the platform's systems. Our roll-up guide shows why that gap exists.
Where the money comes from: the pay reset
The high multiples in private equity deals are real, but a large share of the price is your own future income, paid up front.
Say you earn $900,000 a year from your practice. After the sale, your employment agreement pays you $600,000 for the same clinical work. The $300,000 difference becomes the buyer's profit. At eight times, the buyer pays you $2.4 million for it.
That can be a good trade. You get eight years of the difference today, often taxed as a capital gain rather than as salary, and you no longer carry the business risk. It can also be a bad one if you planned to practice for fifteen more years at full pay, or if the equity part of the price never pays out. Model your income for the next ten years under each offer before you compare multiples.
Cash, rollover and earnouts
Cash at closing is the part you can count on, less any escrow held back against claims.
Rollover equity is the part of your proceeds you reinvest in the buyer. If the fund sells the platform for more than it paid, your stake can be worth much more than you rolled. That is the "second bite of the apple" you will hear about. What you actually receive at that second sale depends on terms buried in documents you signed years earlier: where your equity sits in the payout order, whether investors take a preferred return first, and whether you can be forced to sell.2 Ask for the capital structure, not only the percentage.
Earnouts pay more later if the practice hits targets, usually revenue or EBITDA. Across private-company deals outside life sciences tracked by SRS Acquiom, 22% of 2024 deals had an earnout, and the median earnout could add 31% to the closing payment.3 An earnout tied to results you no longer control is worth less than it looks.
Your job after the sale
You become an employee of the practice entity, usually for several years. Read the employment agreement as closely as the purchase agreement. Look at:
- Compensation. Base pay, productivity pay (often a share of collections or a rate per work RVU), and how either can change.
- Schedule and call. Days, hours, locations, and who decides them.
- Termination. What counts as "cause," whether you can leave without cause, and what that does to your equity and earnout.
- Clinical independence. Who sets protocols, panel size and visit length. California's SB 351, in effect since January 1, 2026, bars private equity groups and hedge funds involved with a physician practice from interfering with physicians' professional judgment, including deciding how many patients a physician sees or how many hours they work.45
Non-competes
You will usually sign more than one. The purchase agreement has a non-compete that protects the goodwill the buyer paid for. The employment agreement has another. Rollover documents can add a third that runs as long as you hold the equity, which can stretch the restriction well past the five-year terms common in purchase agreements.1
State law is moving. Texas limits physician non-competes signed or renewed on or after September 1, 2025 to one year and five miles, with a buyout capped at one year of salary.6 Oregon's SB 951 voids many non-competes between management companies and physicians.7 California's SB 351 bans non-competes in certain management and sale contracts with private equity groups and hedge funds.8 Federally, the FTC dropped its appeal to revive its nationwide non-compete rule in September 2025, then sent warning letters to health care employers about overly broad clauses.9
What the research says
It is fair to ask what happens to practices after private equity buys them. The best-known studies don't flatter the model.
- A 2022 study of 578 dermatology, gastroenterology and ophthalmology practices bought by private equity between 2016 and 2020 found charges per claim rose about 20% and the amount allowed per claim about 11% after acquisition, compared with similar independent practices.10
- A 2023 systematic review in The BMJ found private equity ownership was often associated with higher costs, and with mixed to harmful effects on quality.11
These are averages across many owners. A particular buyer's plan matters more than its label, so ask them how they expect to grow earnings. If the honest answer is higher prices and fewer staff, you know what will happen to your clinic.
States are tightening the rules
- Oregon. SB 951, signed June 9, 2025, sharply limits how much control a management company can have over a medical practice. It applies from January 1, 2026 to arrangements formed after the law took effect, and from January 1, 2029 to older ones.712
- California. SB 351 and AB 1415, signed in October 2025, codify limits on private equity involvement and widen the state's transaction reporting to management companies and private equity groups.8
- Notice laws. As of January 1, 2025, fifteen states required notice of certain health care transactions, and more have been added or expanded since.1314
The market has noticed. PitchBook counted about 747 health care services deals in 2025, up 9.6% on 2024,15 but fourth-quarter activity ran about 15% below the year before, which it partly put down to new state rules on physician practice deals.16
Is it right for you?
Private equity tends to suit physicians who want to keep practicing for at least the length of the employment agreement, are comfortable trading some income for a lump sum, and see real value in the larger company's equity. It tends to disappoint physicians who want to slow down soon, want to keep running the business, or are counting on the second payout to fund retirement.
If you are weighing it, take these questions to every buyer you meet.
Where Hale Fern fits
Hale Fern is a buyer too, and we need a return. Ours is meant to come from taking administrative work off people with AI operations, not from cutting staff or care. We buy the business side and leave the practice, your patients and every clinical decision with you. Hold us to that the same way you would hold anyone else.
Questions owners ask
Will I lose control of my practice?
Of clinical decisions, no. In states with corporate practice of medicine rules, those stay with physicians by law. Business decisions (staffing, vendors, payer contracts, spending) usually move to the management company. The management services agreement spells out who decides what, so read it line by line.
Do I have to take rollover equity?
Most private equity buyers expect some, because it keeps you invested in the result. The amount is negotiable. The terms matter more than the percentage: what class of equity you get, what triggers a buyback, and at what price.17
What happens if I leave before my contract ends?
Read this before you sign. Leaving early can trigger a buyback of your equity, sometimes at a discount, the loss of unpaid earnouts, and a non-compete that keeps you out of your own market. Buyback triggers commonly include breaching a restrictive covenant, ending your employment and indemnity claims.17
Is private equity being banned from health care?
No. Some states now require notice before health care deals close or limit how much control a management company can have, and Oregon and California passed significant laws in 2025.14128 Deals still happen, but they take longer and need more paperwork.
How common is private equity ownership?
Still a minority. In the AMA's 2024 survey, 6.5% of US physicians said their practice was owned by private equity, up from about 4.5% in 2020 and 2022.18
Sources
- Medical Economics, How to understand the difference among potential buyers of your medical practice, 2023.
- Nixon Peabody, The second exit: What happens to physician rollover equity when the platform sells, March 2026.
- SRS Acquiom, 2025 M&A Deal Terms Study, quick reference (private-target deals closed 2019-2024), April 2025.
- California Legislature, via LegiScan, SB 351 (2025), bill text, 2025.
- Epstein Becker Green, California Governor Signs SB 351, Strengthening the State's Corporate Practice of Medicine Doctrine, October 2025.
- Norton Rose Fulbright, Texas Legislature sets new limits on healthcare noncompetes (SB 1318), 2025.
- Proskauer, Oregon Governor Signs SB 951, Representing the Nation's Most Onerous Restriction on the Friendly PC Model, June 2025.
- Private Equity Stakeholder Project, New California laws regulate private equity in healthcare (SB 351 and AB 1415), October 2025.
- Epstein Becker Green, FTC Won't Enforce Its Noncompete Rule, but Noncompete Enforcement Continues, September 2025.
- JAMA Health Forum, Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization (Singh, Song, Polsky, Bruch, Zhu), September 2022.
- The BMJ, Evaluating trends in private equity ownership and impacts on health outcomes, costs, and quality: systematic review (Borsa and colleagues), July 2023.
- Ropes & Gray, Key Takeaways Related to Oregon's New CPOM Law, June 2025.
- Bass, Berry & Sims, Healthcare Private Equity: 2025 Outlook & Trends in M&A, 2025.
- BakerHostetler, Healthcare and Private Equity Transactions Continue to Be Under State Scrutiny, 2026.
- Staffing Industry Analysts, citing PitchBook, A shift in tone across healthcare dealmaking, 2026.
- Becker's Dental, citing PitchBook's Q4 2025 Healthcare Services Report, Private equity deals decline in dentistry: Report, 2026.
- Healio, Equity: Buyback rights, forfeiture and vesting, March 2024.
- American Medical Association, Physician Practice Benchmark Survey: Physician Practice Characteristics in 2024, May 2025.
This guide is general information for clinic owners in the United States and Canada, current as of November 17, 2026. It is not legal, tax or financial advice. Laws differ by state and province, so take any offer to your own lawyer and accountant before you sign.